Regional Business Director
Karyopharm Therapeutics
Regional Business Director
Karyopharm Therapeutics
Develops nuclear export–inhibiting cancer therapies
We are looking for an experienced professional who understands and can live our corporate ICARE values of Innovation, Courage, Alignment/Accountibility, Resilience, and Energy every day as we drive to bring new therapeutics to the market in the fight against cancer. The Regional Business Director provides leadership and direction of field sales representatives to achieve Karyopharm objectives, meet customer needs, foster team development and drive sales of XPOVIO within approved indications.
Reporting to our Vice President, US Sales, you will positively impact patients’ when you:
At Karyopharm, base pay is one part of a competitive total rewards package that includes comprehensive benefits (medical, dental, vision, 401(k), and more), equity and the potential to receive annual target bonuses. Actual pay is based on factors such as location, experience, skills, education, and internal equity. We maintain broad salary ranges to reflect market conditions and the specialized nature of our work. The anticipated base salary range for this position is $230 K –$260 K USD.
At Karyopharm, we live and demonstrate our ICARE values every day! If you want to do something that matters, this work matters. Patients drive our passion to pioneer novel cancer therapies. That’s why we’ve built an environment centered around support, flexibility, and a shared mission.
Creating and delivering medicine for cancer can only be done through focus, dedication, and heart. We hire exceptional people and trust each other to work in whatever way lets us, be us – whether that’s onsite, from home, or anywhere in between.
What do you get when you pair an extraordinary mission with a culture of flexibility and empowerment? We invite you to find out and join us on this incredible mission.
Check out our Culture Video!
What We Offer:
In addition to our exciting, supportive, and intellectually challenging global workspaces(s), team members enjoy a comprehensive and generous benefits package (active on day one) that makes them more productive and contributes directly to the development of their professional skills.
Develops nuclear export–inhibiting cancer therapies
Karyopharm Therapeutics discovers, develops, and commercializes cancer medicines, focusing on hematologic malignancies and solid tumors. Its therapies inhibit nuclear export in cancer cells, keeping tumor-suppressor proteins in the nucleus to trigger cancer cell death and slow tumor growth. The company emphasizes a single core mechanism—nuclear export inhibition—supported by proprietary drugs and in-house development plus collaborations. Its goal is to improve patient outcomes by delivering targeted, mechanism-based therapies and expanding research partnerships.
Explore more opportunities at Karyopharm Therapeutics